Analysts’ Viewpoint on Market Scenario
An increasing number of pharmacists and hospitals are investing in computer systems & software products to ensure robust supply of life-saving drugs & medical devices amid the ongoing COVID-19 pandemic. However, high installation and maintenance cost of healthcare IT & deficient patient engagement activities tend to demotivate physicians & pharmacists to adopt these preventive healthcare technologies.
Hence, stakeholders in the preventive healthcare technologies and services market should increase awareness about the advantages of healthcare IT, which enables long-term cost efficiency and compensates for current high installation costs. The proliferation of digital technologies is expected to augment the growth of the global market.
The rise in demand for technological upgrade of healthcare systems and self-monitoring devices is likely to reduce the cost burden, thus contributing to the growth of the global preventive healthcare technologies and services market.
The global market is driven by favorable government policies for increase in social awareness about vaccination through governmental & non-governmental organizations and adoption of healthcare information technology (IT).
Companies in the preventive healthcare technologies and services market have come under great scrutiny amid ongoing COVID-19 pandemic. The unprecedented demand for flu vaccines has compelled manufacturing units, medical packaging companies, and vaccine delivery centers to streamline processes with the help of healthcare IT.
Good manufacturing practices (GMP) continue to be followed during the entire production process and delivery of life-altering drugs & medical devices. The trend of on-demand products and services is growing prominent in the market. Technologies such as machine learning (ML) are anticipated to gain traction with increasing the adoption of automated prescription systems and computerized provider order entry systems.
Constructive government policies that provide favorable environment for awareness & initiatives for prophylaxis and proliferation of healthcare information technologies are major drivers of the global preventive healthcare technologies and services market. Reduced healthcare cost burden due to penetration of the healthcare information technology and surge in demand for self-monitoring devices are key factors anticipated to propel the global market
However, high installation and maintenance costs have hampered the penetration of preventive technologies in developing economies such as India, Philippines, Bangladesh, and Sri Lanka. The lack of patient engagement activities has demotivated physicians and pharmacists to adopt healthcare IT. However, the COVID-19 pandemic has led to an influx of digital systems, which are expected to increase acceptance for healthcare IT in developing economies. Trends such as telehealth and eHealth mobile apps are expected to augment the market for healthcare IT.
North America is predicted to be the largest and fastest growing region in the preventive healthcare technologies and services market during the assessment period. Presence of major healthcare companies, supportive reimbursement policies, international hub of information technology, and high awareness about preventive healthcare technologies are major factors boosting the expansion of the market in North America.
Technologies such as electronic prescribing, clinical decision supptort sysem, and automated prescription, and formulation & dispensing are still at the nascent stage and expected to drive the market after commercialization. Hence, other regions such as Asia Pacific, Latin America, and Middle East & Africa hold lucrative revenue opportunities with the current market penetration estimated to be low. In all means, healthcare stakeholders in these regions should increase awareness about the advantages of preventive healthcare technologies and services since long-term benefits of these systems have the potential to offset initial installation costs.
Based on early detection & screening technologies, companies in the market are increasing R&D in automated screening technologies and personalized medicine. Personalized medicine was the largest segment of the global market in 2020 due to high investments in genomics research and proteomics. The automated screening segment is likely to expand at a high CAGR during the forecast period due to increasing number of telehealth kiosks by pharmacies & clinics coupled with a high demand for automated melanoma screening techniques.
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 217.09 Mn |
|
Market Forecast Value in 2028 |
US$ 557.47 Mn |
|
Growth Rate (CAGR) |
13% |
|
Forecast Period |
2021–2028 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview. |
|
Format |
Electronic (PDF) |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Preventive Healthcare Technologies and Services Market – Segmentation
TMR’s study on the global market includes information divided into four segments: early detection & screening technologies, prophylaxis technologies, advanced technologies to reduce errors, and chronic disease management technologies. Changing industry trends and other market dynamics associated with these segments of the global preventive healthcare technologies and services industry are discussed in detail.
| Early Detection & Screening Technologies |
|
| Prophylaxis Technologies |
|
| Advanced Technologies to Reduce Errors |
|
| Chronic Disease Management Technologies |
|
The market is expected to reach the value of US$ 557.47 Mn by the end of 2028
The global market is estimated to expand at a CAGR of 13% from 2021 to 2028
the market for Preventive healthcare technologies and services is driven by increase in social awareness about vaccination through governmental & non-governmental organizations
North America accounted for the largest share of the global market
Key players in the global market include Dilon Technologies, Inc., Myraid Genetics, Inc., Noxx Systems, Inc., U-Systems, Inc., Viatronix, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Preventive Healthcare Technologies and Services Market
4. Market Overview
4.1. Introduction
4.1.1. Early Detection & Screening Technologies Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Key Mergers & Acquisitions
5.3. Technological Advancements
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, By Early Detection & Screening Technologies
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028
6.3.1. Personalized Medicine
6.3.2. Automated Screening
6.3.3. Other advanced screening tests
6.4. Market Attractiveness Analysis, By Early Detection & Screening Technologies
7. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, By Prophylaxis Technologies
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028
7.3.1. Influenza Vaccines
7.3.2. Meningococcal Vaccines
7.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
7.3.4. Human Papilloma Virus Vaccine
7.3.5. Other new vaccines
7.4. Market Attractiveness Analysis, By Prophylaxis Technologies
8. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, By Advance Technologies to Reduce Errors
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028
8.3.1. Electronic Prescribing
8.3.2. Computerized Provider Order Entry Systems
8.3.3. Clinical Decision Support System
8.3.4. Automated Prescription, Formulation, and Dispensing
8.3.5. Smart Infusion Pumps
8.3.6. Smart Packaging
8.4. Market Attractiveness Analysis, By Advance Technologies to Reduce Errors
9. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, By Country/Region
10. North America Preventive Healthcare Technologies and Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017- 2028
10.2.1. Personalized Medicine
10.2.2. Automated Screening
10.2.3. Other Advanced Screening Tests
10.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028
10.3.1. Influenza Vaccines
10.3.2. Meningococcal Vaccines
10.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
10.3.4. Human Papilloma Virus Vaccine
10.3.5. Other new vaccines
10.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028
10.4.1. Electronic Prescribing
10.4.2. Computerized Provider Order Entry Systems
10.4.3. Clinical Decision Support System
10.4.4. Automated Prescription, Formulation, and Dispensing
10.4.5. Smart Infusion Pumps
10.4.6. Smart Packaging
10.5. Market Value Forecast, by Country, 2017–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Early Detection & Screening Technologies
10.6.2. By Prophylaxis Technologies
10.6.3. By Advance Technologies to Reduce Errors
10.6.4. By Country
11. Europe Preventive Healthcare Technologies and Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028
11.2.1. Personalized Medicine
11.2.2. Automated Screening
11.2.3. Other Advanced Screening Tests
11.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028
11.3.1. Influenza Vaccines
11.3.2. Meningococcal Vaccines
11.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
11.3.4. Human Papilloma Virus Vaccine
11.3.5. Other new vaccines
11.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028
11.4.1. Electronic Prescribing
11.4.2. Computerized Provider Order Entry Systems
11.4.3. Clinical Decision Support System
11.4.4. Automated Prescription, Formulation, and Dispensing
11.4.5. Smart Infusion Pumps
11.4.6. Smart Packaging
11.5. Market Value Forecast, by Country/Sub-region, 2017–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Early Detection & Screening Technologies
11.6.2. By Prophylaxis Technologies
11.6.3. By Advance Technologies to Reduce Errors
11.6.4. By Country/Sub-region
12. Asia Pacific Preventive Healthcare Technologies and Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028
12.2.1. Personalized Medicine
12.2.2. Automated Screening
12.2.3. Other Advanced Screening Tests
12.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028
12.3.1. Influenza Vaccines
12.3.2. Meningococcal Vaccines
12.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
12.3.4. Human Papilloma Virus Vaccine
12.3.5. Other new vaccines
12.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028
12.4.1. Electronic Prescribing
12.4.2. Computerized Provider Order Entry Systems
12.4.3. Clinical Decision Support System
12.4.4. Automated Prescription, Formulation, and Dispensing
12.4.5. Smart Infusion Pumps
12.4.6. Smart Packaging
12.5. Market Value Forecast, by Country/Sub-region, 2017–2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Early Detection & Screening Technologies
12.6.2. By Prophylaxis Technologies
12.6.3. By Advance Technologies to Reduce Errors
12.6.4. By Country/Sub-region
13. Latin America Preventive Healthcare Technologies and Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028
13.2.1. Personalized Medicine
13.2.2. Automated Screening
13.2.3. Other Advanced Screening Tests
13.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028
13.3.1. Influenza Vaccines
13.3.2. Meningococcal Vaccines
13.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
13.3.4. Human Papilloma Virus Vaccine
13.3.5. Other new vaccines
13.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028
13.4.1. Electronic Prescribing
13.4.2. Computerized Provider Order Entry Systems
13.4.3. Clinical Decision Support System
13.4.4. Automated Prescription, Formulation, and Dispensing
13.4.5. Smart Infusion Pumps
13.4.6. Smart Packaging
13.5. Market Value Forecast, by Country/Sub-region, 2017–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Early Detection & Screening Technologies
13.6.2. By Prophylaxis Technologies
13.6.3. By Advance Technologies to Reduce Errors
13.6.4. By Country/Sub-region
14. Middle East & Africa Preventive Healthcare Technologies and Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028
14.2.1. Personalized Medicine
14.2.2. Automated Screening
14.2.3. Other Advanced Screening Tests
14.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028
14.3.1. Influenza Vaccines
14.3.2. Meningococcal Vaccines
14.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
14.3.4. Human Papilloma Virus Vaccine
14.3.5. Other new vaccines
14.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028
14.4.1. Electronic Prescribing
14.4.2. Computerized Provider Order Entry Systems
14.4.3. Clinical Decision Support System
14.4.4. Automated Prescription, Formulation, and Dispensing
14.4.5. Smart Infusion Pumps
14.4.6. Smart Packaging
14.5. Market Value Forecast, by Country/Sub-region, 2017–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Early Detection & Screening Technologies
14.6.2. By Prophylaxis Technologies
14.6.3. By Advance Technologies to Reduce Errors
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix
15.2. Market Share Analysis, by Company, 2020
15.3. Market Footprint Analysis
15.3.1. By Region
15.3.2. By Early Detection & Screening Technologies Type
15.4. Competitive Business Strategies
15.5. Company Profiles
15.5.1. Alere
15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.1.2. Product Portfolio
15.5.1.3. SWOT Analysis
15.5.1.4. Strategic Overview
15.5.2. Dilon Technologies, Inc.
15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.2.2. Product Portfolio
15.5.2.3. SWOT Analysis
15.5.2.4. Strategic Overview
15.5.3. GlaxoSmithKline plc
15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.3.2. Product Portfolio
15.5.3.3. SWOT Analysis
15.5.3.4. Strategic Overview
15.5.4. Healthways, Inc.
15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.4.2. Product Portfolio
15.5.4.3. SWOT Analysis
15.5.4.4. Strategic Overview
15.5.5. Lifecom, Inc.
15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.5.2. Product Portfolio
15.5.5.3. SWOT Analysis
15.5.5.4. Strategic Overview
15.5.6. Medtronic.
15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.6.2. Product Portfolio
15.5.6.3. SWOT Analysis
15.5.6.4. Strategic Overview
15.5.7. Merck & Co.
15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.7.2. Product Portfolio
15.5.7.3. SWOT Analysis
15.5.7.4. Strategic Overview
15.5.8. Myraid Genetics
15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.8.2. Product Portfolio
15.5.8.3. SWOT Analysis
15.5.8.4. Strategic Overview
15.5.9. Novx Systems, Inc.
15.5.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.9.2. Product Portfolio
15.5.9.3. SWOT Analysis
15.5.9.4. Strategic Overview
15.5.10. Omnicell, Inc.
15.5.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.10.2. Product Portfolio
15.5.10.3. SWOT Analysis
15.5.10.4. Strategic Overview
15.5.11. Omron Healthcare, Inc.
15.5.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.11.2. Product Portfolio
15.5.11.3. SWOT Analysis
15.5.11.4. Strategic Overview
15.5.12. Sanofi Pasteur MSD
15.5.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.12.2. Product Portfolio
15.5.12.3. SWOT Analysis
15.5.12.4. Strategic Overview
15.5.13. Scripto LLC
15.5.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.13.2. Product Portfolio
15.5.13.3. SWOT Analysis
15.5.13.4. Strategic Overview
15.5.14. U-Systems, Inc.
15.5.14.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.14.2. Product Portfolio
15.5.14.3. SWOT Analysis
15.5.14.4. Strategic Overview
List of Tables
Table 01: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Early Detection & Screening Technologies, 2017–2028
Table 02: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Personalized Medicine, 2017–2028
Table 03: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Automated Screening, 2017–2028
Table 04: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Other Advanced Screening Tests, 2017–2028
Table 05: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Prophylaxis Technologies, 2017–2028
Table 06: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Advance Technologies to Reduce Errors, 2017–2028
Table 07: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Region, 2017–2028
Table 08: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Country, 2017–2028
Table 09: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Early Detection & Screening Technologies, 2017–2028
Table 10: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Personalized Medicine, 2017–2028
Table 11: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Automated Screening, 2017–2028
Table 12: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Other Advanced Screening Tests, 2017–2028
Table 13: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Prophylaxis Technologies, 2017–2028
Table 14: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Advance Technologies to Reduce Errors, 2017–2028
Table 15: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 16: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Early Detection & Screening Technologies, 2017–2028
Table 17: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Personalized Medicine, 2017–2028
Table 18: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Automated Screening, 2017–2028
Table 19: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Other Advanced Screening Tests, 2017–2028
Table 20: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Prophylaxis Technologies, 2017–2028
Table 21: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Advance Technologies to Reduce Errors, 2017–2028
Table 22: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 23: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, Early Detection & Screening Technologies, 2017–2028
Table 24: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Personalized Medicine, 2017–2028
Table 25: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Automated Screening, 2017–2028
Table 26: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Other Advanced Screening Tests, 2017–2028
Table 27: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Prophylaxis Technologies, 2017–2028
Table 28: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Early Detection & Screening Technologies, 2017–2028
Table 29: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 30: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, Early Detection & Screening Technologies, 2017–2028
Table 31: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Personalized Medicine, 2017–2028
Table 32: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Automated Screening, 2017–2028
Table 33: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Other Advanced Screening Tests, 2017–2028
Table 34: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Prophylaxis Technologies, 2017–2028
Table 35: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Early Detection & Screening Technologies, 2017–2028
Table 36: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 37: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Personalized Medicine, 2017–2028
Table 38: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Automated Screening, 2017–2028
Table 39: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Automated Screening, 2017–2028
Table 40: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Other Advanced Screening Tests, 2017–2028
Table 41: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Prophylaxis Technologies, 2017–2028
Table 42: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, Early Detection & Screening Technologies, 2017–2028
List of Figures
Figure 01: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, 2017–2028
Figure 02: Global Preventive Healthcare Technologies and Services Market Value Share Analysis, by Early Detection & Screening Technologies, 2017 and 2028
Figure 03: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Personalized Medicine, 2017–2028
Figure 04 Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Automated Screening, 2017–2028
Figure 05: Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2028
Figure 06: Global Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Prophylaxis Technologies, 2017–2028
Figure 07: Global Preventive Healthcare Technologies and Services Market Value Share Analysis, by Flu Vaccines, 2017 and 2028
Figure 08: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Meningococcal Vaccines, 2017–2028
Figure 09: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Combined Tetanus-Diphtheria-Pertussis Vaccines, 2017–2028
Figure 10: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Human Papilloma Virus Vaccine, 2017–2028
Figure 11: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others New Vaccine, 2017–2028
Figure 12: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Advance Technologies to Reduce Errors, 2017–2028
Figure 13: Global Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Electronic Prescribing, 2018 - 2028
Figure 14: Global Preventive Healthcare Technologies and Services Market Value Share Analysis, by Computerized Provider Order Entry Systems, 2017 and 2028
Figure 15: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Clinical Decision Support System, 2017–2028
Figure 16: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Automated Prescription, Formulation, and Dispensing, 2017–2028
Figure 17: Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Smart Infusion Pumps, 2017–2028
Figure 18: Global Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Smart Packaging, 2017-2028
Figure 19: Global Preventive Healthcare Early Detection & Screening Technologies, 2017-2028
Figure 20: Global Preventive Healthcare Technologies and Services Market Value Share Analysis, by Region, 2017 and 2026
Figure 21: Global Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Region
Figure 22: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 23: North America Preventive Healthcare Technologies and Services Market Value Share (%), by Country, 2017 and 2028
Figure 24: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country, 2017–2028
Figure 25: North America Preventive Healthcare Technologies and Services Market Value Share (%), by Early Detection & Screening Technologies, 2017 and 2028
Figure 26: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Early Detection & Screening Technologies, 2017–2028
Figure 27: North America Preventive Healthcare Technologies and Services Market Value Share (%), by Prophylaxis Technologies, 2017 and 2028
Figure 28: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Prophylaxis Technologies, 2017–2028
Figure 29: North America Preventive Healthcare Technologies and Services Market Value Share (%), by Advance Technologies to Reduce Errors, 2017 and 2028
Figure 30: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Advance Technologies to Reduce Errors, 2018–2028
Figure 31: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 32: Europe Preventive Healthcare Technologies and Services Market Value Share (%), by Country/Sub-region, 2017 and 2028
Figure 33: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country/Sub-region, 2017–2028
Figure 34: Europe Preventive Healthcare Technologies and Services Market Value Share (%), by Early Detection & Screening Technologies, 2017 and 2028
Figure 35: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Early Detection & Screening Technologies, 2018–2028
Figure 36: Europe Preventive Healthcare Technologies and Services Market Value Share (%), by Prophylaxis Technologies, 2017 and 2028
Figure 37: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Prophylaxis Technologies, 2017–2028
Figure 38: Europe Preventive Healthcare Technologies and Services Market Value Share (%), by Advance Technologies to Reduce Errors, 2017 and 2028
Figure 39: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Advance Technologies to Reduce Errors, 2017–2028
Figure 40: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 41: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share (%), by Country/Sub-region, 2017 and 2028
Figure 42: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country/Sub-region, 2017–2028
Figure 43: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share (%), by Early Detection & Screening Technologies, 2017 and 2028
Figure 44: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Early Detection & Screening Technologies, 2017–2028
Figure 45: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share (%), by Prophylaxis Technologies, 2017 and 2028
Figure 46: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by , 2017–2028
Figure 47: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share (%), by Advance Technologies to Reduce Errors, 2017 and 2028
Figure 48: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Advance Technologies to Reduce Errors, 2018–2028
Figure 49: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 50: Latin America Preventive Healthcare Technologies and Services Market Value Share (%), by Country/Sub-region, 2017 and 2028
Figure 51: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country/Sub-region, 2017–2028
Figure 52: Latin America Preventive Healthcare Technologies and Services Market Value Share (%), by Early Detection & Screening Technologies, 2017 and 2028
Figure 53: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Early Detection & Screening Technologies, 2018–2028
Figure 54: Latin America Preventive Healthcare Technologies and Services Market Value Share (%), by Prophylaxis Technologies, 2017 and 2028
Figure 55: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Prophylaxis Technologies, 2017–2028
Figure 56: Latin America Preventive Healthcare Technologies and Services Market Value Share (%), by Advance Technologies to Reduce Errors, 2017 and 2028
Figure 57: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Advance Technologies to Reduce Errors, 2018–2028
Figure 58: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2028
Figure 59: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share (%), by Country/Sub-region, 2017 and 2028
Figure 60: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country/Sub-2018–2028
Figure 61: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share (%), by Early Detection & Screening Technologies, 2017 and 2028
Figure 62: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Early Detection & Screening Technologies, 2018–2028
Figure 63: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share (%), by Prophylaxis Technologies, 2017 and 2028
Figure 64: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Prophylaxis Technologies, 2018–2028
Figure 65: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share (%), by Advance Technologies to Reduce Errors, 2017 and 2028
Figure 66: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Advance Technologies to Reduce Errors, 2017–2028
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Preventive Healthcare Technologies and Services Market
